Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma - Zhang, Y., Ishida, C. T., Ishida, W., Lo, S.-F. L., Zhao, J., Shu, C., Bianchetti, E., Kleiner, G., Sanchez-Quintero, M. J., Quinzii, C. M., Westhoff, M.-A., Karpel-Massler, G., Canoll, P., Siegelin, M. D. (The American Association for Cancer Research (AACR), 2018)
6319716